Operation ASHA and Baxter India (later acquired by Takeda) collaborated applied Operation ASHA’s entire model including mHealth Applications for detection and treatment of disadvantaged hemophilia patients. The program was implemented in a population of nearly 8.4 million people living in thousands of urban shanties and villages in the states of Haryana and Uttar Pradesh in India. These areas are distinct from the areas in which Operation ASHA implements the TB Program.
The Program resulted in improving detection of patients by over 3 times by detecting 342 additional patients. It also improved adherence to therapy by increasing drug consumption per patient by over 75% in a year. This proved the hypothesis many experts had held for a long time that Operation ASHA’s model is agnostic to disease. It can be applied to any disease, or as a matter of fact, to distribute any product or service to the disadvantaged at a low cost.